Catheter control systems

Information

  • Patent Grant
  • 11350815
  • Patent Number
    11,350,815
  • Date Filed
    Thursday, July 9, 2015
    9 years ago
  • Date Issued
    Tuesday, June 7, 2022
    2 years ago
Abstract
A medical manipulation assembly comprises a catheter including distal and proximal steerable portions with working channels. The assembly further comprises a steerable sheath through which the steerable portions extend. A distal steering mechanism, including a first lumen extending along a longitudinal axis of the catheter, bends the distal steerable portion. A proximal steering mechanism, including a second lumen extending along the axis and defined by a wall, bends the proximal steerable portion by rotational movement of the proximal steering mechanism independently of the distal steerable portion. The wall is rotatable about the axis. Distal pullwires extend between the distal steerable portion and the distal steering mechanism. Proximal pullwires extend between the proximal steerable portion and the proximal steering mechanism. The second lumen is axially aligned with an access lumen extending proximally from the proximal steering mechanism through which the distal and proximal working channels may receive a visualization instrument.
Description
FIELD OF THE INVENTION

The present invention relates generally to catheter control systems for controlling the articulation of visualization and treatment apparatus having imaging and manipulation features for intravascularly accessing regions of the body.


BACKGROUND OF THE INVENTION

Conventional devices for accessing and visualizing interior regions of a body lumen are known. For example, various catheter devices are typically advanced within a patient's body, e.g., intravascularly, and advanced into a desirable position within the body. Other conventional methods have utilized catheters or probes having position sensors deployed within the body lumen, such as the interior of a cardiac chamber. These types of positional sensors are typically used to determine the movement of a cardiac tissue surface or the electrical activity within the cardiac tissue. When a sufficient number of points have been sampled by the sensors, a “map” of the cardiac tissue may be generated.


Another conventional device utilizes an inflatable balloon which is typically introduced intravascularly in a deflated state and then inflated against the tissue region to be examined. Imaging is typically accomplished by an optical fiber or other apparatus such as electronic chips for viewing the tissue through the membrane(s) of the inflated balloon. Moreover, the balloon must generally be inflated for imaging. Other conventional balloons utilize a cavity or depression formed at a distal end of the inflated balloon. This cavity or depression is pressed against the tissue to be examined and is flushed with a clear fluid to provide a clear pathway through the blood.


However, many of the conventional catheter imaging systems lack the capability to provide therapeutic treatments or are difficult to manipulate in providing effective therapies. For instance, the treatment in a patient's heart for atrial fibrillation is generally made difficult by a number of factors, such as visualization of the target tissue, access to the target tissue, and instrument articulation and management, amongst others.


Conventional catheter techniques and devices, for example such as those described in U.S. Pat. Nos. 5,895,417; 5,941,845; and 6,129,724, used on the epicardial surface of the heart may be difficult in assuring a transmural lesion or complete blockage of electrical signals. In addition, current devices may have difficulty dealing with varying thickness of tissue through which a transmural lesion is desired.


Conventional accompanying imaging devices, such as fluoroscopy, are unable to detect perpendicular electrode orientation, catheter movement during the cardiac cycle, and image catheter position throughout lesion formation. The absence of real-time visualization also poses the risk of incorrect placement and ablation of structures such as sinus node tissue which can lead to fatal consequences.


Moreover, because of the tortuous nature of intravascular access, devices or mechanisms at the distal end of a catheter positioned within the patient's body, e.g., within a chamber of the heart, are typically no longer aligned with the handle. Steering or manipulation of the distal end of the catheter via control or articulation mechanisms on the handle is easily disorienting to the user as manipulation of a control on the handle in a first direction may articulate the catheter distal end in an unexpected direction depending upon the resulting catheter configuration leaving the user to adjust accordingly. However, this results in reduced efficiency and longer procedure times as well as increased risks to the patient. Accordingly, there is a need for improved catheter control systems which facilitate the manipulation and articulation of a catheter.


BRIEF SUMMARY OF THE INVENTION

A tissue imaging and manipulation apparatus that may be utilized for procedures within a body lumen, such as the heart, in which visualization of the surrounding tissue is made difficult, if not impossible, by medium contained within the lumen such as blood, is described below. Generally, such a tissue imaging and manipulation apparatus comprises an optional delivery catheter or sheath through which a deployment catheter and imaging hood may be advanced for placement against or adjacent to the tissue to be imaged.


The deployment catheter may define a fluid delivery lumen therethrough as well as an imaging lumen within which an optical imaging fiber or assembly may be disposed for imaging tissue. When deployed, the imaging hood may be expanded into any number of shapes, e.g., cylindrical, conical as shown, semi-spherical, etc., provided that an open area or field is defined by the imaging hood. The open area is the area within which the tissue region of interest may be imaged. The imaging hood may also define an atraumatic contact lip or edge for placement or abutment against the tissue region of interest. Moreover, the distal end of the deployment catheter or separate manipulatable catheters may be articulated through various controlling mechanisms such as push-pull wires manually or via computer control


The deployment catheter may also be stabilized relative to the tissue surface through various methods. For instance, inflatable stabilizing balloons positioned along a length of the catheter may be utilized, or tissue engagement anchors may be passed through or along the deployment catheter for temporary engagement of the underlying tissue.


In operation, after the imaging hood has been deployed, fluid may be pumped at a positive pressure through the fluid delivery lumen until the fluid fills the open area completely and displaces any blood from within the open area. The fluid may comprise any biocompatible fluid, e.g., saline, water, plasma, Fluorinert™, etc., which is sufficiently transparent to allow for relatively undistorted visualization through the fluid. The fluid may be pumped continuously or intermittently to allow for image capture by an optional processor which may be in communication with the assembly.


In an exemplary variation for imaging tissue surfaces within a heart chamber containing blood, the tissue imaging and treatment system may generally comprise a catheter body having a lumen defined therethrough, a visualization element disposed adjacent the catheter body, the visualization element having a field of view, a transparent fluid source in fluid communication with the lumen, and a barrier or membrane extendable from the catheter body to localize, between the visualization element and the field of view, displacement of blood by transparent fluid that flows from the lumen, and an instrument translatable through the displaced blood for performing any number of treatments upon the tissue surface within the field of view. The imaging hood may be formed into any number of configurations and the imaging assembly may also be utilized with any number of therapeutic tools which may be deployed through the deployment catheter.


More particularly in certain variations, the tissue visualization system may comprise components including the imaging hood, where the hood may further include a membrane having a main aperture and additional optional openings disposed over the distal end of the hood. An introducer sheath or the deployment catheter upon which the imaging hood is disposed may further comprise a steerable segment made of multiple adjacent links which are pivotably connected to one another and which may be articulated within a single plane or multiple planes. The deployment catheter itself may be comprised of a multiple lumen extrusion, such as a four-lumen catheter extrusion, which is reinforced with braided stainless steel fibers to provide structural support. The proximal end of the catheter may be coupled to a handle for manipulation and articulation of the system.


To provide visualization, an imaging element such as a fiberscope or electronic imager such as a solid state camera, e.g., CCD or CMOS, may be mounted, e.g., on a shape memory wire, and positioned within or along the hood interior. A fluid reservoir and/or pump (e.g., syringe, pressurized intravenous bag, etc.) may be fluidly coupled to the proximal end of the catheter to hold the translucent fluid such as saline or contrast medium as well as for providing the pressure to inject the fluid into the imaging hood.


One example of a system configured to enable direct visualization of tissue underlying the hood and optionally treat tissue, e.g., ablation, may include an ablation assembly, hood, and deployment catheter coupled to a handle having a catheter steering and locking assembly integrated along the handle. The catheter steering and locking assembly may include a steering member pivotably coupled to a locking member where the steering member may be coupled to one or more pullwires attached thereto via a retaining member, e.g., set screw, such that manipulation of the steering member articulates the steerable section and hood in a corresponding manner. The steering member may be pivotably coupled to the locking member along a point of rotation and locking mechanism which is attached to a steering plate.


The catheter shaft contains at least one lumen which allows the passage of one or more pullwires that are connected to the steering member at the proximal end of the pullwire while the distal end may be terminated and anchored to the steering mechanisms along the steerable portion of the catheter. A compression coil, e.g., made of stainless steel, with a slightly larger diameter than the pullwire may be positioned about the pullwire within the handle to allow the pullwire to slide freely therethrough.


In use, the steering member may be actuated, e.g., by pulling the member proximally, to articulate the steerable portion and hood in the same direction of articulation. With the steerable portion articulated to the degree desired to position the hood, the locking member may be actuated to maintain a configuration of the steerable portion and hood by preventing or inhibiting movement of the steering member thus freeing the hand or hands of the user. A steering indicator and/or locking indicator may be optionally incorporated along the handle as a reminder to the user.


The handle assembly may also optionally incorporate an optical adjustment assembly which may be used to move the distal lens of a visualization instrument, such as a fiberscope, distally or proximally from the imaged tissue region, hence simulating a zoom-in and/or zoom-out optical effect. Generally, the optical adjustment assembly is able to provide zoom-in and/or zoom-out capabilities by varying the length of the assembly. By rotating an adjustment member, which is coupled to a retaining sleeve within the optical adjustment assembly, a distal shaft portion may be advanced or retracted relative to the guide shaft. The assembly may be accordingly varied in length while distally or proximally advancing the fiberscope based on the varied length of the optical adjustment assembly to control the visualized field of view.


Because manipulation of the hood and steerable portion corresponds with an angle at which the handle is positioned, the handle may also serve as an orientation indicator for the hood and steerable portion once the hood has been introduced into the patient's body. This correspondence between the planes of the handle and the resulting articulation of the hood and steerable-portion may be particularly useful for efficiently controlling the hood position within the patient's body. As the catheter is usually repeatedly torqued during a procedure, keeping track of the orientation of the deflection of the hood can be difficult, if not impossible, unless fluoroscopy is used. With the handle, the angle of deflection of the hood can be predicted by the operator without the need of fluoroscopy. This is can be particularly desirable in procedures such as transseptal punctures where an accurate angle of puncture of the septal wall is desirable to avoid complications such as perforation of the aorta.


Another variation of a steering handle assembly may include an assembly having a handle portion and a steering ring which may be manipulated along any number of directions relative to the housing to control the articulation of the hood. Manipulating or pulling along a portion of the steering ring causes the steerable portion and hood to move along a corresponding direction of articulation. Moreover, because of the manner in which the steering ring is positioned to encircle the handle assembly, the operator may grip the handle along any orientation and operate the handle assembly with a single hand.


The handle assembly may generally comprise a ball pivot supported by pivot support enclosed within the housing. The ball pivot may support the steering ring via one or more steering ring support members, e.g., four steering ring support members, which extend radially through corresponding support member openings. Because of the ball pivot shape, the steering ring may be moved about the pivot in any number of directions. The terminal ends of one or more pullwires may be coupled the steering ring via corresponding fasteners, e.g., set screws, securing each of the pullwire termination crimps. These pullwires may extend through the pivot support housing and through a pullwire transition manifold and into a proximal end of a multi-lumen shaft, such as the catheter. The pullwires may continue distally through the catheter where they are coupled to the steerable portion of the catheter. Each of the pullwires may be optionally encased in corresponding compression coils between the transition manifold and catheter.


Although multiple pullwires may be utilized depending upon the number of directions for articulation, four pullwires may be typically utilized. Each of the four pullwires may be terminated symmetrically around a circumference of the steering ring such that a balanced four-way steering of the distal portion may be accomplished, although manipulating the steering ring along various portions of its circumference may yield combinational articulation between the pullwires to result in numerous catheter configurations. Additionally, the handle assembly may further incorporate a spring mechanism as an overdrive prevention mechanism positioned between the transition manifold and ball pivot in order to prevent over-tensioning or breaking of the pullwires if the steering ring is over-deflected in a direction.


The handle assembly and catheter can be consistently deflected in the same direction by which the steering ring is being deflected regardless of the orientation of the handle assembly. For example, the handle assembly may be deflected in a first direction of actuation such that the hood is deflected in a corresponding first direction of articulation. If the handle assembly, catheter, and hood are then rotated along an arbitrary direction of rotation about the longitudinal axis of the assembly, even with the entire assembly rotated, e.g., 180°, actuating the steering ring along the first direction of actuation still results in a corresponding first direction of articulation of the hood which matches the initial direction of articulation despite the rotated assembly.


In yet another variation of the catheter control handle, the control assembly may be configured to articulate at least two independently deflectable portions. As with previous variations, a steering ring may encircle the housing. However, this variation further includes a proximal handle portion extending from the housing with a proximal section control for articulating the proximal steerable section. Moreover, this particular handle assembly may be used to control articulation of the hood and the distal steerable section but also used to further control articulation of the proximal steerable section. A proximal section control located along the proximal handle portion may be actuated, e.g., by rotating the control in a first and/or second direction, to articulate the proximal steerable section within a first plane and the hood may be further articulated by manipulating the steering ring such that distal steerable section moves in a corresponding direction of articulation.


Additionally and/or alternatively, visual indicators positioned directly upon the hood may also be utilized in coordination with corresponding visual indicators positioned upon the handle itself. The hood may have one or more visual indicators marked upon the distal portion of the hood such that the visual image through the hood may show at least a first directional indicator along a first portion of the hood. The handle assembly may thus have one or more directional indicators located directly upon, e.g., the steering ring, which correspond spatially with the indicators positioned upon the hood or hood membrane.


The catheter control systems described herein may additionally integrate any number of features and controls for facilitate procedures. These features and controls may be integrated into any of the variations described herein. One example may include features such as flow rate control, air bubble detection, ablation activation switches, built-in image sensors, etc., may be incorporated into the handle assembly.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A shows a side view of one variation of a tissue imaging apparatus during deployment from a sheath or delivery catheter.



FIG. 1B shows the deployed tissue imaging apparatus of FIG. 1A having an optionally expandable hood or sheath attached to an imaging and/or diagnostic catheter.



FIG. 1C shows an end view of a deployed imaging apparatus.



FIGS. 2A and 2B show one example of a deployed tissue imager positioned against or adjacent to the tissue to be imaged and a flow of fluid, such as saline, displacing blood from within the expandable hood.



FIGS. 3A and 3B show examples of various visualization imagers which may be utilized within or along the imaging hood.



FIGS. 4A and 4B show perspective and end views, respectively, of an imaging hood having at least one layer of a transparent elastomeric membrane over the distal opening of the hood.



FIGS. 5A and 5B show perspective and end views, respectively, of an imaging hood which includes a membrane with an aperture defined therethrough and a plurality of additional openings defined over the membrane surrounding the aperture.



FIG. 6 illustrates an assembly view of another example of a visualization system configured for a controlled articulation and manipulation of the end effector.



FIG. 7A shows a side view of one example of a handle with access lumens and visualization instrumentation extending therefrom.



FIG. 7B shows a detail side view of an example of a steering and locking mechanism located upon the handle.



FIGS. 8A and 8B show side views of an example of a visualization and treatment catheter having a steerable distal end articulated by a steering member and locked into position.



FIG. 9 shows a perspective exploded assembly view of an example of the catheter steering and locking assembly.



FIG. 10A shows a perspective exploded assembly view of an optional optical adjustment assembly which may be used to provide for zooming in and out of a visualization instrument, such as a fiberscope, through the catheter.



FIGS. 10B and 10C illustrate cross-sectional side views of the optical adjustment assembly showing the relative movement of the assembly to convey the visualization instrument distally and proximally to adjust visual images.



FIG. 11 shows a perspective view of an optional access cannula having a stabilizing strain-relief wire for coupling to a handle.



FIG. 12 shows a side view of a handle assembly positioned to lie within a first plane correspondingly aligned with a second plane defined by a deflection of the steerable distal section.



FIGS. 13A and 13B show an example where a visualization hood has been advanced intravascularly within a patient's heart with a handle positioned external to the patient and illustrates how re-orienting the handle, e.g., by 90°, results in a corresponding articulation of the plane defined by the visualization hood and distal section within the heart.



FIG. 14 shows an assembly view of another variation of the handle which is configured to manipulate the steerable distal section in multiple directions by a single hand of the user.



FIG. 15 shows a detail side view of the handle of FIG. 14.



FIG. 16 illustrates a single hand of the user manipulating a multi-directional steering ring located on the handle.



FIGS. 17A and 17B show cross-sectional side views of the handle illustrating the multiple pullwires attached to the steering ring.



FIGS. 18A to 18C show side views of the handle assembly illustrating how the handle is configured to articulate and steer the visualization hood consistently in the same direction when urged by the steering ring in the same direction regardless of the handle orientation.



FIG. 19 shows an assembly view of yet another variation of the handle which is configured to manipulate the steerable distal section in multiple directions as well as curve yet another steerable section located proximal to the distal section.



FIGS. 20A and 20B show side views, respectively, of the catheter control system handle.



FIGS. 21A and 21B show end views of the catheter control handle from the perspective of the catheter shaft and from the handle end, respectively.



FIGS. 22A and 22B show perspective assembly and detail views, respectively, of the visualization assembly and catheter control handle.



FIG. 23A shows a perspective view of a steerable proximal portion of the catheter actuated by a proximal section control located along the handle.



FIG. 23B shows a perspective view of the steerable distal portion of the catheter further steered by actuation of the steering ring to maneuver the visualization hood relative to the steerable proximal portion.



FIG. 24 shows a perspective exploded assembly view of the catheter control handle.



FIG. 25 shows a cross-sectional side view of the catheter control handle.



FIG. 26 shows a cross-sectional detail side view of the catheter control handle having the pullwires in place for controlling both the distal and proximal portions.



FIGS. 27A and 27B show side views of die control handle under single-handed manipulation whether by a user's right hand or left hand, respectively.



FIG. 28 shows a perspective view of the control handle having an orientation guide located on the handle for reference to the user.



FIGS. 29A and 29B show another example where a visualization hood has been advanced intravascularly within a patient's heart with the control handle positioned external to the patient and illustrates how re-orienting the handle, e.g., by 90°, results in a corresponding articulation of the plane defined by the visualization hood and distal section within the heart.



FIGS. 30A and 30B show an end view of the hood from the perspective of an imager positioned within the hood and a side view of the control handle having orientation markers on the steering ring which correspond to similar orientation marks positioned along the hood.



FIG. 30C shows a perspective view illustrating how manipulation of the steering ring in the direction of a particular marker results in a corresponding movement of the visualization hood in a direction as correlated to the marker indicated on the hood.



FIG. 31 shows an assembly view of yet another variation of the control handle incorporating multiple features.



FIG. 32 shows an assembly view of how an imaging system may be incorporated directly within the control handle.





DETAILED DESCRIPTION OF THE INVENTION

A tissue-imaging and manipulation apparatus described herein is able to provide real-time images in vivo of tissue regions within a body lumen such as a heart, which is filled with blood flowing dynamically therethrough and is also able to provide intravascular tools and installments for performing various procedures upon the imaged tissue regions. Such an apparatus may be utilized for many procedures, e.g., facilitating transseptal access to the left atrium, cannulating the coronary sinus, diagnosis of valve regurgitation/stenosis, valvuloplasty, atrial appendage closure, arrhythmogenic focus ablation, among other procedures.


One variation of a tissue access and imaging apparatus is shown in the detail perspective views of FIGS. 1A to 1C. As shown in FIG. 1A, tissue imaging and manipulation assembly 10 may be delivered intravascularly through the patient's body in a low-profile configuration via a delivery catheter or sheath 14. In the case of treating tissue, it is generally desirable to enter or access the left atrium while minimizing trauma to the patient. To non-operatively effect such access, one conventional approach involves puncturing the intra-atrial septum from the right atrial chamber to the left atrial chamber in a procedure commonly called a transseptal procedure or septostomy. For procedures such as percutaneous valve repair and replacement, transseptal access to the left atrial chamber of the heart may allow for larger devices to be introduced into the venous system than can generally be introduced percutaneously into the arterial system.


When the imaging and manipulation assembly 10 is ready to be utilized for imaging tissue, imaging hood 12 may be advanced relative to catheter 14 and deployed from a distal opening of catheter 14, as shown by the arrow. Upon deployment, imaging hood 12 may be unconstrained to expand or open into a deployed imaging configuration, as shown in FIG. 1B. Imaging hood 12 may be fabricated from a variety of pliable or conformable biocompatible material including but not limited to, e.g., polymeric, plastic, or woven materials. One example of a woven material is Kevlar® (E. I. du Pont de Nemours, Wilmington, Del.), which is an aramid and which can be made into thin, e.g., less than 0.001 in., materials which maintain enough integrity for such applications described herein. Moreover, the imaging hood 12 may be fabricated from a translucent or opaque material and in a variety of different colors to optimize or attenuate any reflected lighting from surrounding fluids or structures, i.e., anatomical or mechanical structures or instruments. In either case, imaging hood 12 may be fabricated into a uniform structure or a scaffold-supported structure, in which case a scaffold made of a shape memory alloy, such as Nitinol, or a spring steel, or plastic, etc., may be fabricated and covered with the polymeric, plastic, or woven material. Hence, imaging hood 12 may comprise any of a wide variety of barriers or membrane structures, as may generally be used to localize displacement of blood or the like from a selected volume of a body lumen or heart chamber. In exemplary embodiments, a volume within an inner surface 13 of imaging hood 12 will be significantly less than a volume of the hood 12 between inner surface 13 and outer surface 11.


Imaging hood 12 may be attached at interface 24 to a deployment catheter 16 which may be translated independently of deployment catheter or sheath 14. Attachment of interface 24 may be accomplished through any number of conventional methods. Deployment catheter 16 may define a fluid delivery lumen 18 as well as an imaging lumen 20 within which an optical imaging fiber or assembly may be disposed for imaging tissue. When deployed, imaging hood 12 may expand into any number of shapes, e.g., cylindrical, conical as shown, semi-spherical, etc., provided that an open area or field 26 is defined by imaging hood 12. The open area 26 is the area within which the tissue region of interest may be imaged. Imaging hood 12 may also define an atraumatic contact lip or edge 22 for placement or abutment against the tissue region of interest. Moreover, the diameter of imaging hood 12 at its maximum fully deployed diameter, e.g., at contact lip or edge 22, is typically greater relative to a diameter of the deployment catheter 16 (although a diameter of contact lip or edge 22 may be made to have a smaller or equal diameter of deployment catheter 16). For instance, the contact edge diameter may range anywhere from 1 to 5 times (or even greater, as practicable) a diameter of deployment catheter 16. FIG. 1C shows an end view of the imaging hood 12 in its deployed configuration. Also shown are the contact lip or edge 22 and fluid delivery lumen 18 and imaging lumen 20.


As seen in the example of FIGS. 2A and 2D, deployment catheter 16 may be manipulated to position deployed imaging hood 12 against or near the underlying tissue region of interest to be imaged, in this example a portion of annulus A of mitral valve MV within the left atrial chamber. As the surrounding blood 30 flows around imaging hood 12 and within open area 26 defined within imaging hood 12, as seen in FIG. 2A, the underlying annulus A is obstructed by the opaque blood 30 and is difficult to view through the imaging lumen 20. The translucent fluid 28, such as saline, may then be pumped through fluid delivery lumen 18, intermittently or continuously, until the blood 30 is at least partially, and preferably completely, displaced from within open area 26 by fluid 28, as shown in FIG. 2B.


Although contact edge 22 need not directly contact the underlying tissue, it is at least preferably brought into close proximity to the tissue such that the flow of clear fluid 28 from open area 26 may be maintained to inhibit significant backflow of blood 30 back into open area 26. Contact edge 22 may also be made of a soft elastomeric material such as certain soft grades of silicone or polyurethane, as typically known, to help contact edge 22 conform to an uneven or rough underlying anatomical tissue surface. Once the blood 30 has been displaced from imaging hood 12, an image may then be viewed of the underlying tissue through the clear fluid 30. This image may then be recorded or available for real-time viewing for performing a therapeutic procedure. The positive flow of fluid 28 may be maintained continuously to provide for clear viewing of the underlying tissue. Alternatively, the fluid 28 may be pumped temporarily or sporadically only until a clear view of the tissue is available to be imaged and recorded, at which point the fluid flow 28 may cease and blood 30 may be allowed to seep or flow back into imaging hood 12. This process may be repeated a number of times at the same tissue region or at multiple tissue regions.



FIG. 3A shows a partial cross-sectional view of an example where one or more optical fiber bundles 32 may be positioned within the catheter and within imaging hood 12 to provide direct in-line imaging of the open area within hood 12. FIG. 3B shows another example where an imaging element 34 (e.g., CCD or CMOS electronic imager) may be placed along an interior surface of imaging hood 12 to provide imaging of the open area such that the imaging element 34 is off-axis relative to a longitudinal axis of the hood 12, as described in further detail below. The off-axis position of element 34 may provide for direct visualization and uninhibited access by instruments from the catheter to the underlying tissue during treatment.


In utilizing the imaging hood 12 in any one of the procedures described herein, the hood 12 may have an open field which is uncovered and clear to provide direct tissue contact between the hood interior and the underlying tissue to effect any number of treatments upon the tissue, as described above. Yet in additional variations, imaging hood 12 may utilize other configurations. An additional variation of the imaging hood 12 is shown in the perspective and end views, respectively, of FIGS. 4A and 4B, where imaging hood 12 includes at least one layer of a transparent elastomeric membrane 40 over the distal opening of hood 12. An aperture 42 having a diameter which is less than a diameter of the outer lip of imaging hood 12 may be defined over the center of membrane 40 where a longitudinal axis of the hood intersects the membrane such that the interior of hood 12 remains open and in fluid communication with the environment external to hood 12. Furthermore, aperture 42 may be sized, e.g., between 1 to 2 mm or more in diameter and membrane 40 can be made from any number of transparent elastomers such as silicone, polyurethane, latex, etc. such that contacted tissue may also be visualized through membrane 40 as well as through aperture 42.


Aperture 42 may function generally as a restricting passageway to reduce the rate of fluid out-flow from the hood 12 when the interior of the hood 12 is infused with the clear fluid through which underlying tissue regions may be visualized. Aside from restricting out-flow of clear fluid from within hood 12, aperture 42 may also restrict external surrounding fluids from entering hood 12 too rapidly. The reduction in the rate of fluid out-flow from the hood and blood in-flow into the hood may improve visualization conditions as hood 12 may be more readily filled with transparent fluid rather than being filled by opaque blood which may obstruct direct visualization by the visualization installments.


Moreover, aperture 42 may be aligned with catheter 16 such that any installments (e.g., piercing instruments, guidewires, tissue engagers, etc.) that are advanced into the hood interior may directly access the underlying tissue uninhibited or unrestricted for treatment through aperture 42. In other variations wherein aperture 42 may not be aligned with catheter 16, installments passed through catheter 16 may still access the underlying tissue by simply piercing through membrane 40.


In an additional variation, FIGS. 5A and 5B show perspective and end views, respectively, of imaging hood 12 which includes membrane 40 with aperture 42 defined therethrough, as described above. This variation includes a plurality of additional openings 44 defined over membrane 40 surrounding aperture 42. Additional openings 44 may be uniformly sized, e.g., each less than 1 mm in diameter, to allow for the out-flow of the translucent fluid therethrough when in contact against the tissue surface. Moreover, although openings 44 are illustrated as uniform in size, the openings may be varied in size and their placement may also be non-uniform or random over membrane 40 rather than uniformly positioned about aperture 42 in FIG. 5B. Furthermore, there are eight openings 44 shown in the figures although fewer than eight or more than eight openings 44 may also be utilized over membrane 40.


Additional details of tissue imaging and manipulation systems and methods which may be utilized with apparatus and methods described herein are further described, for example, in U.S. patent application Ser. No. 11/259,498 filed Oct. 25, 2005 (U.S. Pat. Pub. 2006/0184048 A1), which is incorporated herein by reference in its entirety.


In utilizing the devices and methods above, various procedures may be accomplished. One example of such a procedure is crossing a tissue region such as in a transseptal procedure where a septal wall is pierced and traversed, e.g., crossing from a right atrial chamber to a left atrial chamber in a heart of a subject. Generally, in piercing and traversing a septal wall, the visualization and treatment devices described herein may be utilized for visualizing the tissue region to be pierced as well as monitoring the piercing and access through the tissue. Details of transseptal visualization catheters and methods for transseptal access which may be utilized with the apparatus and methods described herein are described in U.S. patent application Ser. No. 11/763,399 filed Jun. 14, 2007 (U.S. Pat. Pub. 2007/0293724 A1), which is incorporated herein by reference in its entirety. Additionally, details of tissue visualization and manipulation catheter which may be utilized with apparatus and methods described herein are described in U.S. patent application Ser. No. 11/259,498 filed Oct. 25, 2005 (U.S. Pat. Pub. 2006/0184048 A1), which is incorporated herein by reference in its entirety.



FIG. 6 illustrates one example of a system configured to enable direct visualization of tissue underlying hood 12 and optionally tissue treatment, e.g., ablation. As shown in ablation assembly 50, hood 12 and deployment catheter 16 are coupled to handle 52, as previously described. Fluid reservoir 56, shown in this example as a saline-filled bag reservoir, may be attached through handle 52 to provide the clearing fluid and/or ablation medium. An optional access cannula 54 is also illustrated attached to handle 52 and may be used in one variation as an access lumen for flushing or clearing a working channel through handle 52 and catheter 16 where such a working channel may be used to introduce and advance any number of instruments for tissue treatment, e.g., an access needle which may be advanced into handle 52 and into or through hood 12. An optical imaging assembly 58 coupled to an imaging element positioned within or adjacent to hood 12 may extend proximally through handle 52 and be coupled to imaging processor assembly 60 (which may also optionally include a light source) for processing the images detected within hood 12. Assembly may also be coupled to a video receiving assembly 62 for receiving images from the optical imaging assembly 58. The video receiving assembly 62 may in turn be coupled to video processor assembly 64 which may process the detected images within hood 12 for display upon video display 68.



FIGS. 7A and 7B show a side view of a variation of the catheter control handle assembly and a detail side view of the handle 52 having a catheter steering and locking assembly 70 integrated along the handle 52. As shown, handle 52 may have several access channels defined through which allow for communication for any number of instruments into and/or through the catheter 16 and hood 12. For instance, a fluid catheter 86 may be positioned at least partially through fluid channel 88 within handle 52. The optical imaging assembly 58, e.g., a fiberscope or CCD or CMOS imaging assembly, maybe positioned through support shaft 94 and support shaft interface 96 which enters handle 52. In the case where a fiberscope is utilized, the fiberscope shaft 82 may be passed through an optional optical adjustment assembly 84, as described in further detail below. Another working channel 80 may be further defined through handle 52 to allow for entry and passage of yet another instrument, e.g., a piercing needle, ablation probe, etc.


Also shown is catheter steering and locking assembly 70 integrated along the handle 52 having a steering member 72 pivotably coupled to a locking member 74. Steering member 72 may be coupled to one or more pullwires 78 attached thereto via retaining member 92, e.g., set screw, such that manipulation of the steering member articulates the steerable section and hood in a corresponding manner. Steering member 72 may be pivotably coupled to locking member 74 along a point of rotation and locking mechanism 76 which is attached to a steering plate 90.


The catheter shaft contains at least one lumen which allows the passage of one or more pullwires that are connected to the steering member 72 at the proximal end of the pullwire while the distal end may be terminated and anchored to the steering mechanisms along the steerable portion 100 of the catheter 16. Details of steering mechanisms and steerable sections of the visualization catheter, which may be utilized with apparatus and methods described herein are described in U.S. patent application Ser. No. 12/108,812 filed Apr. 24, 2008 and Ser. No. 12/117,655 filed May 8, 2008, each of which is incorporated herein by reference in its entirety. The one or more pullwires can be made from metal such as stainless steel or nitinol. A compression coil, e.g., made of stainless steel, with a slightly larger diameter than the pullwire may be positioned about the pullwire within the handle 52 to allow the pullwire to slide freely therethrough. The ends of the compression coil may be glue jointed to the proximal end to the catheter body and the distal end to the side wall of the shaft. Alternatively, the pullwire may be passed through a hypo tube made of stainless steel and be anchored at the distal side wall of the catheter 16.


In use, steering member 72 may be actuated, e.g., by pulling the member proximally, to articulate the steerable portion 100 and hood 12 in the same direction of articulation 102, as shown in the side view of FIG. 8A. With the steerable portion 100 articulated to the degree desired to position hood 12, locking member 74 may be actuated, e.g., in the direction of locking 104, to maintain a configuration of steerable portion 100 and hood 12 by preventing or inhibiting movement of steering member 72, as shown in the side view of FIG. 8B, thus freeing the hand or hands of the user. A steering indicator 106 and/or locking indicator 108 may be optionally incorporated along handle 52 as a reminder to the user.



FIG. 9 illustrates a perspective view of an exploded steering and locking assembly. As shown, the locking member 74 may define an opening 112 which is keyed to locking mechanism 76, e.g., lock hex nut, such that the locking mechanism 76 rotates when locking member 74 is rotated. Locking mechanism 76 may also pass through an opening 114 defined along the steering member 72 as well as through an opening 116 defined through the steering plate 90 such that a terminal end of the locking mechanism 76 is coupled to lock bolt 118. Once the one or more pullwires, which may be secured within pullwire passage 120 defined through the steering member 72 by set screw 92, is pulled to a desired degree by steering member 72, locking member 74 may be rotated about axis of rotation 110 to drive locking mechanism 76 into the lock bolt 118 to compress the steering member 72 between the steering plate 90 and the locking member 74. Hence, steering member 72 is locked in its current position when locking member 74 is applied thereby holding the steerable section in its desired configuration.


As previously mentioned, the handle assembly may also optionally incorporate an optical adjustment assembly 84, as shown in the perspective exploded assembly view of FIG. 10A. The optical adjustment assembly 84 may be used to move the distal lens of a visualization instrument, such as a fiberscope, distally or proximally from the imaged tissue region, hence simulating a zoom-in and/or zoom-out optical effect. Generally, the optical adjustment assembly 84 is able to provide zoom-in and/or zoom-out capabilities by varying the length of the assembly. As depicted in the cross-sectional side views of FIGS. 10B and 10C, an adjustment member 130 houses guide shaft 134 which extends proximally through receiving channel 132 of adjustment member 130 and is retained within by a retaining lip 136. The proximally extending sliding shaft portion 144 of a second shaft is positioned slidably within guide shaft 134 while the distally extending distal shaft portion 142 of this second shaft is positioned within a sleeve opening 152 of retaining sleeve 150, which is also positioned within adjustment member 130. This second shaft further comprises a threaded guide 146 along a portion of its outer surface which is configured to engage rotatably with the inner surface of sleeve opening 152, which is also threaded in a complementary manner.


With the shafts assembled, one or more fasteners 158, e.g., set screw, may be used to secure adjustment member 130 to retaining sleeve 150 through fastener opening 156 defined through member 130 and fastener interface 154 defined along retaining sleeve 150. Distally extending distal shaft portion 142 may further define connector interface 148 for coupling to a retaining luer connector 160 while guide shaft 134 may also define a connector interface 138 for coupling to a luer connector 140. In use, the shaft of a visualization instrument such as a fiberscope may be positioned through and secured to the assembly 84 by one or more of the connectors, e.g., luer connector 160. By rotating adjustment member 130, which is coupled to retaining sleeve 150, distal shaft portion 142 may be advanced or retracted relative to guide shaft 134 via the threaded engagement between threaded guide 146 and sleeve opening 152. The assembly 84 may be accordingly varied in length while distally or proximally advancing the fiberscope based on the varied length of the optical adjustment assembly 84 to control the visualized field of view.


Also previously mentioned above, the optical imaging assembly 58 may be optionally positioned through a support shaft 94 and support shaft interface 96 which enters handle 52, as shown in the perspective view of FIG. 11. Support shaft 94 may be longitudinally reinforced to protect the optical fiber used by the visualization catheter from buckling or breaking. To maintain a position of shaft 94 relative to the handle into which the shaft 94 extends, shaft 94 may incorporate a strain relief wire 162 which protrudes from the distal end of shaft 94 at an angle for temporarily locking within a wire channel 164, as shown above in FIG. 7B. Once wire 162 has been engaged within channel 164 within the handle, shaft 94 may provide stability to the fiberscope shaft. The wire 162 can be made from stainless steel or nitinol and have a thickness between, e.g., 0.050″ to 0.100″.


Because manipulation of the hood 12 and steerable portion corresponds with an angle at which the handle is positioned, handle 52 may also serve as an orientation indicator for the hood 12 and steerable portion once the hood 12 has been introduced into the patient's body. As shown in the side view of FIG. 12, the handle 52 may define a plane A. Articulation of hood 12 and the steerable portion may thus also define a plane A′ which corresponds planarly to the plane A defined by the handle 52. This correspondence between the planes A, A′ of the handle 52 and the resulting articulation of the hood 12 and steerable portion may be particularly useful for efficiently controlling the hood position within the patient's body. As the catheter 16 is usually repeatedly torqued during a procedure, keeping track of the orientation of the deflection of the hood 12 can be difficult, if not impossible, unless fluoroscopy is used. With the handle 52, the angle of deflection of the hood 12 can be predicted by the operator without the need of fluoroscopy. This is can be particularly desirable in procedures such as transseptal punctures where an accurate angle of puncture of the septal wall is desirable to avoid complications such as perforation of the aorta.


An example of how this feature may be utilized is shown in the illustrations of FIGS. 13A and 13B, which show a hood positioned within the right atrium of a heart H while coupled to handle 52 positioned external to the body. Handle 52 may be seen as being positioned along plane A while hood 12 and the distal portion of catheter 16 is positioned within corresponding plane A′. As handle 52 is rotated, e.g., at 90°, about its longitudinal axis in a direction of rotation 170 such that handle 52 then lies within a different plane B, hood 12 and the distal steerable portion may also rotate, e.g., at 90°, within the right atrium in a corresponding direction of rotation 170′ such that the hood and catheter then define a corresponding different plane B′. Thus, by merely articulating the handle 52 external to the body in a specified direction, the user may adjust or desirably position or re-position the hood within the body in a known direction without having to utilize additional catheter positioning mechanisms.



FIG. 14 shows an assembly view of another variation of a steering handle assembly 180 which enables a user to steer the visualization hood 12 along at least four or more degrees of freedom relative to a longitudinal axis of the catheter 16. FIG. 15 shows a side view of the handle assembly 180 illustrating handle portion 182 and steering ring 184 which may be manipulated along any number of directions relative to housing 186 to control the articulation of the hood 12. As shown in FIG. 16, manipulating or pulling along a portion of steering ring 184, e.g., along a direction of actuation 192, causes steerable portion 100 and hood 12 to move along a corresponding direction of articulation 194. Moreover, because of the manner in which steering ring 184 is positioned to encircle the handle assembly 180, the operator may grip the handle 180 along any orientation and operate the handle assembly 180 with a single hand 190. For instance, the operator may manipulate the steering ring with the thumb and/or index finger while insertion length of the catheter 16 can also be simultaneously controlled by the same hand 190 by pulling or pushing the handle assembly 180 to translate the entire catheter 16.


As shown in the cross-sectional side views of FIGS. 17A and 17B, handle assembly 180 may generally comprise a ball pivot 200 supported by pivot support 202 enclosed within housing 186. Ball pivot 200 may support the steering ring 184 via one or more steering ring support members 204, 206, e.g., four steering ring support members, which extend radially through corresponding support member openings 208, 210. Because of the ball pivot 200 shape, steering ring 184 may be moved about pivot 200 in any number of directions. The terminal ends of one or more pullwires 220, 222 may be coupled steering ring 184 via corresponding fasteners 212, 214, e.g., set screws, securing each of the pullwire termination crimps 216, 218. These pullwires 220, 222 may extend through pivot support housing 224 which defines receiving channel 226, which supports pivot support 202, and through pullwire transition manifold 228 and into a proximal end of a multi-lumen shaft 234, such as catheter 16. The pullwires may continue distally through catheter 16 where they are coupled to the steerable portion of catheter 16. Each of the pullwires may be optionally encased in corresponding compression coils 230, 232 between the transition manifold 228 and catheter.


Although multiple pullwires may be utilized depending upon the number of directions for articulation, four pullwires may be typically utilized. Each of the four pullwires may be terminated symmetrically around a circumference of steering ring 184 such that a balanced four-way steering of the distal portion may be accomplished, although manipulating the steering ring 184 along various portions of its circumference may yield combinational articulation between the pullwires to result in numerous catheter configurations. Additionally, the handle assembly may further incorporate a spring mechanism 236 as an overdrive prevention mechanism, as shown in FIG. 17B. Spring mechanism 236 may be positioned between the transition manifold 228 and ball pivot 200 in order to prevent over-tensioning or breaking of the pullwires if the steering ring 184 is over-deflected in a direction.



FIGS. 18A to 18C illustrate side views of the handle assembly 180 and catheter 16 to show how the hood 12 can be consistently deflected in the same direction by which the steering ring 184 is being deflected regardless of the orientation of the handle assembly 180. For example, handle assembly 180 may be deflected in a direction of actuation 240 such that hood 12 is deflected in a corresponding direction of articulation 242. A first side indicator X of handle 180 and a second opposing side indicator Y of handle 180 are shown to indicate a first position of handle 180 and the corresponding first side indicator X′ of hood 12 and corresponding second opposing side indicator Y′ of hood 12 are likewise shown to indicate a first position of hood 12. The handle assembly 180, catheter 16, and hood 12 are then rotated along an arbitrary direction of rotation 244 about longitudinal axis 246 of the assembly such that the handle positional indicators X, Y and the hood positional indicators X′, Y′ are now positioned in opposite locations. Even with the entire assembly rotated, e.g., 180°, actuating the steering ring 184 along the direction of actuation 248 still results in a corresponding direction of articulation 250 of hood 12 which matches the initial direction of articulation 242 despite the rotated assembly. Regardless of the angle by which the operator subsequently rotates the catheter 16 about the longitudinal axis 246, the operator can still be certain that deflecting the steering ring 184 in a particular direction will steer the distal end of the catheter in the same direction. This removes the need for the operator to memorize the original position of the catheter or how much the catheter has been torqued in order to gauge the orientation of the deflected end when the catheter is inserted into the patient.


In yet another variation of the catheter control handle, FIG. 19 shows an assembly view of steering handle assembly 260 which is configured to articulate a catheter 16 having at least two independently deflectable portions, e.g., a proximal steerable section 262 adapted to articulate within a single plane relative to a longitudinal axis of the catheter and a distal steerable section 264 adapted to articulate within one or more planes relative to a longitudinal axis of the proximal steerable section 262. Utilizing such catheter steering may be particularly advantageous for tissue treatment, e.g., ablation, in the left atrium of the heart as such adaptability in steering may impart additional accuracy and efficiency to steer the imaging and ablation hood 12 around complex anatomical structures, such as the pulmonary vein ostium. Examples of such steerable catheters are shown and described in further detail in U.S. patent application Ser. No. 12/108,812 filed Apr. 24, 2008 (U.S. Pat. Pub. 2008/0275300 A1) and Ser. No. 12/117,655 filed May 8, 2008 (U.S. Pat. Pub. 2008/0281293 A1), each of which is incorporated herein by reference in its entirety.


Moreover, this handle variation as well as any of the other handle variations herein may incorporate any of the features described in each of the variations, as practicable. For instance, this particular variation may also utilize the optical adjustment assembly, locking mechanisms, etc. in combination if so desired.



FIGS. 20A and 20B show side views of the steering handle assembly 260 with the catheter 16 having proximal steerable section 262 and distal steerable section 264 extending from distal handle portion 274. As with previous variations, a steering ring 270 may encircle housing 272. However, this variation further includes a proximal handle portion 276 extending from housing 272 with a proximal section control 278 for articulating proximal steerable section 262. FIGS. 21A and 21B show end views of the control handle 260 from the perspective of the catheter shaft 16 and from the handle end, respectively. As shown, steering ring 270 may be supported by a number of steering ring support members 280, 282, 284, 286 which extend from housing 272 through corresponding support member openings 288, 290, 282, 294. FIGS. 22A and 22B show additional perspective assembly and detail views, respectively, of the visualization assembly and steering handle assembly 260.


As previously described for other variations, this particular handle assembly 260 may be used to control articulation of the hood 12 and the distal steerable section 264 but also used to further control articulation of the proximal steerable section 262. As shown in the perspective view of FIG. 23A, proximal section control 278 may be actuated, e.g., by rotating the control 278 in a first direction 300, to articulate the proximal steerable section 262 within a first plane, e.g., to retroflex hood 12 and distal steerable section 264 in a corresponding direction of articulation 302. Hood 12 may be further articulated by manipulating steering ring 270, e.g., in a direction of actuation 304, such that distal steerable section 264 moves in a corresponding direction of articulation 306, as shown in FIG. 23B. In one variation, proximal steerable section 262 may be configured to articulate via proximal section control 278 within a single plane while distal steerable section 264 may be configured to articulate in at least four directions, as above. However, both the proximal section control 278 and the steering ring 270 can be manipulated in varying degrees to steer the respective steerable sections to varying curvatures as desired by the operator.



FIG. 24 shows a perspective exploded assembly view of the handle assembly 260 while FIG. 25 shows a cross-sectional side view of the same handle assembled. As shown, a ball pivot 310 having a pivot support 312 may be supported within a proximal portion of distal handle portion 274. One or more steering ring support members 314 may extend through respective openings defined through housing 272 to support the circumferentially encircling steering ring 270. As above, a pullwire transition manifold 316 may be positioned proximal to the catheter 16 entrance.


A guide shaft 322 may be positioned at least partially through proximal handle portion 276 while maintained in position by retaining lip 324. A sliding shaft portion 328 may be positioned slidably within guide shaft 322 while a distal shaft portion 326 may extend distally through housing 272. A pullwire retaining member 318 having a pullwire termination crimp 320 may be positioned along a distal end of distal shaft portion 326 such that as distal shaft portion 326 is translated distally and/or proximally according to the manipulation of section control 278, the pullwire for the proximal steerable section 262 may be accordingly pulled or pushed. The distal shaft portion 326 may further have a threaded guide 330 which is engaged to a threaded inner surface of retaining sleeve 332, which is secured to section control 278. Thus, as control 278 is rotated, retaining sleeve 332 is also rotated thereby urging distal shaft portion 326 and sliding shaft portion 328 to move accordingly via the engagement with threaded guide 330. A further access lumen 334 is illustrated as extending through the handle assembly 260.


As further illustrated in the cross-sectional side view of FIG. 26, the one or more proximal steerable section pullwire 342 is shown as extending from catheter 16 and extending through transition manifold 316 and terminated at pullwire retaining member 318. Additionally, one or more distal steerable section pullwires 338, 340 are also shown to emerge from catheter 16, through one or more corresponding compression coils 336, and through transition manifold 316 to terminate at corresponding pullwire termination crimps 348, 350, which may be secured to steering ring 270 via fasteners 344, 346, e.g., set screws. The distal ends these pullwires, e.g., at least four pullwires, can be anchored to the inner walls of the distal steerable section 264. At both the proximal as well as the distal ends, the pullwires may be separated, e.g., by 90°, such that the four-way steerable section is able to be steered symmetrically in at least four directions.


The ends of the compression coils 336 may be glue jointed to the proximal end to the catheter body 16 and distally into the transition manifold 316. Alternatively, the pullwires may also be passed through hypodermic tubes and anchored at the distal side wall of the catheter shaft 16 and the transition manifold 316. Moreover, the pullwires may be made from materials such as stainless steel or nitinol and flexible thin wall compression coils, such as stainless steel coils, may be further slid over each pullwire along the catheter shaft 16.


Because of the design of the handle assembly 260 and the accessibility of the steering ring 270 to the user, the user may utilize a single hand to operate the handle assembly 260 to control and manipulate the catheter 16 and hood 12 configuration and position within the patient's body. Moreover, the operator may utilize either their right hand 360, e.g., by gripping handle portion 276, or their left hand 362, e.g., by gripping distal handle portion 274, as shown respectively in FIGS. 27A and 27B.


As previously described, because the catheter 16 and hood 12 may be repeatedly torqued and repositioned within the patient's body during a procedure, keeping track of the orientation of the deflection of the hood 12 can be difficult, if not impossible, unless fluoroscopy is used. As the handle assembly 260 provides an indication, as described herein, as to which direction the catheter and hood may be configured based upon the handle orientation, an orientation guide 372 may be imprinted directly upon the handle 274, as shown in detail view 370 of FIG. 28. The plane within which the orientation guide 372 lies may be configured to be parallel to the plane within which the proximal steerable section 262 articulates when section control 278 is manipulated such that the operator may be able to predict how the catheter 16 will configure when manipulated.


As similarly described above, FIGS. 29A and 29B illustrate a hood positioned within the right atrium of a heart H while coupled to handle assembly 260 positioned external to the body. Handle assembly 260 may be seen as being positioned along plane A while hood 12 and the distal portion of catheter 16 is positioned within corresponding plane A′. As handle assembly 260 is rotated, e.g., at 90°, about its longitudinal axis in a direction of rotation 380 such that handle assembly 260 then lies within a different plane B, hood 12 and the distal steerable portion may also rotate, e.g., at 90°, within the right atrium in a corresponding direction of rotation 380′ such that the hood and catheter then define a corresponding different plane B′. Thus, by merely articulating the handle assembly 260 external to the body in a specified direction, the user may adjust or desirably position or re-position the hood within the body in a known direction without having to utilize additional catheter positioning mechanisms.


Additionally and/or alternatively, visual indicators positioned directly upon the hood 12 may also be utilized in coordination with corresponding visual indicators positioned upon the handle itself. The hood 12 may have one or more visual indicators marked upon the distal portion of the hood such that the visual image 390 through the hood may show at least a first directional indicator 392′ along a first portion of the hood, as shown in FIG. 30A. In this example, a second directional indicator 394′ and yet a third corresponding third indicator 396′ may be positioned about a circumference of the hood or hood membrane to represent any number of directions. Handle assembly 260 may thus have one or more directional indicators located directly upon, e.g., steering ring 270, which correspond spatially with the indicators positioned upon the hood or hood membrane, as shown in FIG. 30B. For instance, first directional indicator 392′ on the hood may correspond spatially with first directional indicator 392 on steering ring 270, second directional indicator 394 on the hood may correspond spatially with second directional indicator 394′ on steering ring 270, third directional indicator 396 on the hood may correspond with third directional indicator 396′ on steering ring 270, and so on. Although three directional indicators are shown in this example, fewer than three or more than three may be utilized. Moreover, the location and positioning of the indicators may also be varied, as desired.


In use, the directional indicators as viewed through the hood correspond to the direction the hood may move when the steering ring 270 is deflected along the position where the corresponding indicator is located. Thus, deflecting steering ring 270 in direction of actuation 398, e.g., along directional indicator 394, may articulate distal steerable section 264 and hood 12 in a corresponding direction of articulation 400 along the directional indicator 394′ shown on the hood or hood membrane, as shown in FIG. 30C. This removes complexity in steering the hood 12, e.g., when the hood 12 is in a retroflexed position, where directions are reversed with respect to the operator.


The catheter control systems described herein may additionally integrate any number of features and controls for facilitate procedures. These features and controls may be integrated into any of the variations described herein. FIG. 31 shows one example where features such as flow rate control, air bubble detection, ablation activation switches, built-in image sensors, etc., may be incorporated into the handle assembly.


As shown on handle 52, a flow control 410 switch may be incorporated which may optionally have a high-flow position 412, a no-flow position 414, and an optional suction position 416 to control the inflow and/or outflow of the visualization and/or ablation fluid. One or more fluid reservoirs, e.g., a room temperature purging fluid reservoir 422 and/or a chilled purging fluid reservoir 424, may be fluidly coupled to a processing unit 418 which may control various parameters, e.g., valves, inflow, suction, RF ablation energy generation, bubble detection, etc. Processing unit 418 may also incorporate a pump 420, e.g., peristaltic pump, which may pump or urge the fluids from the reservoir through one or more coupling lines into and/or out from handle 52. Processing unit 418 may also be electrically coupled to handle 52 and may also be able to process, display and store several data, including total amount of saline used for the entire procedure, power and duration of ablation, impedance of tissue in contact with hood, rate of flow of saline, temperature of saline, and time of detection of air bubbles during the procedure.


In the event that handle 52 is used to suction or evacuate fluids out from the body, an additional evacuation reservoir 426 may also be fluidly coupled to handle 52. Additionally, one or more hemostasis valves 428 may also be integrated directly upon handle 52. Moreover, an imaging sensor 430 which may also incorporate a light source, e.g., LEDs, and power supply, may additionally be integrated directly into handle 52. A video cable may be connected to the proximal end of the handle 52 and can be directly plugged into any standard video display monitors (such as ones accepting S-Video, DVI, VGA, RCA inputs), rather than utilizing a separate video processing unit.


As processing unit 418 may incorporate processors for detecting various physiological parameters, one or more detection indicators 432, e.g., for bubble detection, and/or ablation actuation switch 434 may be integrated directly upon the handle 52 as an indicator to the operator. If air bubbles are detected in the irrigation channel, the detection indicator 432 may be activated to alert the operator of air bubbles. A soft alarm may also be triggered to further alert the operator. Additionally, with an ablation actuation switch 434 located directly upon handle 52, the operator may be able to instantaneously activate or stop ablation energy from being delivered to the target tissue by depressing switch 434 rather than reaching for a separate ablation generator. Details for tissue ablation under direct visualization and detecting various parameters such as bubble formation are also shown and described in further detail in U.S. patent application Ser. No. 12/118,439 filed May 9, 2008 (U.S. Pat. Pub. 2009/0030412 A1), which is incorporated herein by reference in its entirety.


Another example of an integrated handle is shown illustratively in FIG. 32. In this example, handle 274 may incorporate an imaging system directly into the handle. As illustrated, the images captured by the imager 440 positioned within or along hood 12 may be focused onto an electronic imaging sensor 444, e.g., CMOS sensor, positioned within handle 274. Imaging sensor 444 may deliver the images directly to the video processor. A light source 448, e.g., LED light source, may also be placed within the handle 274 to deliver light through, e.g., an optical fiber 442 positioned within hood 12, to illuminate the tissue region to be visualized. At the terminal end of the fiber bundle, a focus lens 446, e.g., a combination of spherical lenses, may be positioned proximal to the fiber bundle. An alternative may utilize a GRIN lens which may be used as a simple one piece element which is chromatically aberration corrected and polarization preserved to allow for more design flexibility. Moreover, a GRIN lens is typically more economical than the spherical lenses.


The applications of the disclosed invention discussed above are not limited to certain treatments or regions of the body, but may include any number of other applications as well. Modification of the above-described methods and devices for carrying out the invention, and variations of aspects of the invention that are obvious to those of skill in the arts are intended to be within the scope of this disclosure. Moreover, various combinations of aspects between examples are also contemplated and are considered to be within the scope of this disclosure as well.

Claims
  • 1. A medical manipulation assembly comprising: a catheter including an elongated distal steerable portion with a distal working channel extending through the elongated distal steerable portion and an elongated proximal steerable portion proximal of the elongated distal steerable portion with a proximal working channel extending through the elongated proximal steerable portion, the elongated distal steerable portion and the elongated proximal steerable portion extending along a longitudinal axis of the catheter;a steerable sheath through which the catheter extends such that the distal and proximal steerable portions extend distally of a distal end of the steerable sheath;a distal steering mechanism operable to bend the distal steerable portion in response to movement of the distal steering mechanism, wherein the distal steering mechanism includes a first elongated lumen extending along the longitudinal axis of the catheter;a proximal steering mechanism positioned proximal to the distal steering mechanism, the proximal steering mechanism being operable to bend the proximal steerable portion by rotational movement of the proximal steering mechanism, independently of the distal steerable portion, wherein the proximal steering mechanism includes a second elongated lumen defined by a wall, wherein the second elongated lumen extends along the longitudinal axis of the catheter and the wall is rotatable about the longitudinal axis;one or more distal pullwires extending between the elongated distal steerable portion and the distal steering mechanism; andone or more proximal pullwires extending between the elongated proximal steerable portion and the proximal steering mechanism,wherein the second elongated lumen is axially aligned with an access lumen extending proximally from the proximal steering mechanism, and wherein the distal and proximal working channels are configured to receive a visualization instrument through the access lumen.
  • 2. The medical manipulation assembly of claim 1 wherein the distal steering mechanism is operable to bend the distal steerable portion in response to pivoting movement of the distal steering mechanism.
  • 3. The medical manipulation assembly of claim 1 further comprising the visualization instrument, wherein the visualization instrument is extendable distally beyond the proximal and distal steerable portions.
  • 4. The medical manipulation assembly of claim 3 wherein the visualization instrument is a camera.
  • 5. The medical manipulation assembly of claim 3 wherein the visualization instrument includes a plurality of optical fibers.
  • 6. The medical manipulation assembly of claim 1 wherein at least one of the proximal or distal steering mechanisms is operable by computer control.
  • 7. The medical manipulation assembly of claim 1 wherein the distal and proximal working channels are configured for passage of an irrigation fluid therethrough.
  • 8. The medical manipulation assembly of claim 1 wherein the distal and proximal working channels are configured for passage of an ablation instrument therethrough.
  • 9. The medical manipulation assembly of claim 1 further comprising a lighting source extending within the distal steerable portion.
  • 10. The medical manipulation assembly of claim 1 wherein the one or more proximal and distal pullwires include a compression coil.
  • 11. A method performed by a computing system, the method comprising: moving a distal steering mechanism to bend an elongated distal steerable portion of a catheter, the distal steerable portion including a distal working channel, the distal steering mechanism including a first elongated lumen extending along a longitudinal axis of the catheter;rotating a proximal steering mechanism positioned proximal to the distal steering mechanism, independently of the movement of the distal steerable mechanism, to bend an elongated proximal steerable portion of the catheter, the proximal steerable portion extending proximally of the elongated distal steerable portion and including a proximal working channel, the proximal steering mechanism including a second elongated lumen defined by a wall, the second elongated lumen extending along the longitudinal axis of the catheter as the wall is rotatable about the longitudinal axis of the catheter, the catheter extending through a steerable sheath such that the distal and proximal steerable portions extend distally of a distal end of the steerable sheath, the elongated distal steerable portion and the proximal steerable portion extending along the longitudinal axis of the catheter;responsive to the movement of the distal steering mechanism, manipulating one or more distal pullwires extending between the elongated distal steerable portion and the distal steering mechanism to bend the distal steerable portion; andresponsive to the rotating of the proximal steering mechanism, manipulating one or more proximal pullwires extending between the elongated proximal steerable portion and the proximal steering mechanism to bend the proximal steerable portion,wherein the second elongated lumen is axially aligned with an access lumen extending proximally from the proximal steering mechanism, and wherein the distal and proximal working channels are configured to receive a visualization instrument through the access lumen.
  • 12. The method of claim 11 wherein moving the distal steering mechanism includes pivoting the distal steering mechanism.
  • 13. The method of claim 11 further comprising extending the visualization instrument distally beyond the proximal and distal steerable portions.
  • 14. The method of claim 11 wherein the visualization instrument is a camera.
  • 15. The method of claim 11 wherein the visualization instrument includes a plurality of optical fibers.
  • 16. The method of claim 11 further comprising displaying an image obtained by the visualization instrument.
  • 17. The method of claim 11 further comprising conveying an irrigation fluid through the distal and proximal working channels.
  • 18. The method of claim 11 further comprising receiving an ablation instrument through the distal and proximal working channels.
  • 19. The method of claim 11 further comprising operating a lighting source positioned within the distal steerable portion.
  • 20. The method of claim 11 wherein the one or more proximal and distal pullwires include a compression coil.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 12/499,011 filed on Jul. 7, 2009 and issued as U.S. Pat. No. 9,101,735 which claims the benefit of priority to U.S. Prov. Pat. App. 61/078,746 filed Jul. 7, 2008, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (579)
Number Name Date Kind
623022 Johnson Apr 1899 A
2306462 Wolf Dec 1942 A
2453862 Salisbury Nov 1948 A
3557780 Sato Jan 1971 A
3559651 David Feb 1971 A
3874388 King et al. Apr 1975 A
4175545 Termanini Nov 1979 A
4326529 Doss et al. Apr 1982 A
4445892 Hussein et al. May 1984 A
4470407 Hussein Sep 1984 A
4517976 Murakoshi et al. May 1985 A
4531943 Van Tassel Jul 1985 A
4569335 Tsuno Feb 1986 A
4576146 Kawazoe et al. Mar 1986 A
4615333 Taguchi Oct 1986 A
4619247 Inoue et al. Oct 1986 A
4676258 Inokuchi et al. Jun 1987 A
4681093 Ono Jul 1987 A
4709698 Johnston et al. Dec 1987 A
4710192 Liotta et al. Dec 1987 A
4727418 Kato et al. Feb 1988 A
4784133 Mackin Nov 1988 A
4848323 Marijnissen et al. Jul 1989 A
4873965 Danieli Oct 1989 A
4911148 Sosnowski et al. Mar 1990 A
4914521 Adair Apr 1990 A
4943290 Rexroth et al. Jul 1990 A
4950285 Wilk Aug 1990 A
4957484 Murtfeldt Sep 1990 A
4961738 Mackin Oct 1990 A
4976710 Mackin Dec 1990 A
4991578 Cohen Feb 1991 A
4994069 Ritchart et al. Feb 1991 A
4998916 Hammerslag et al. Mar 1991 A
4998972 Chin et al. Mar 1991 A
5047028 Qian Sep 1991 A
5057106 Kasevich et al. Oct 1991 A
5090959 Samson et al. Feb 1992 A
5123428 Schwarz Jun 1992 A
RE34002 Adair Jul 1992 E
5156141 Krebs et al. Oct 1992 A
5171259 Inoue Dec 1992 A
5254088 Lundquist Oct 1993 A
5281238 Chin et al. Jan 1994 A
5282827 Kensey et al. Feb 1994 A
5306234 Johnson Apr 1994 A
5313943 Houser et al. May 1994 A
5325845 Adair Jul 1994 A
5330496 Alferness Jul 1994 A
5334159 Turkel Aug 1994 A
5334193 Nardella Aug 1994 A
5336252 Cohen Aug 1994 A
5339800 Wiita et al. Aug 1994 A
5348554 Imran et al. Sep 1994 A
5352237 Rodak Oct 1994 A
5353792 Luebbers et al. Oct 1994 A
5370647 Graber et al. Dec 1994 A
5373840 Knighton Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5385148 Lesh et al. Jan 1995 A
5391182 Chin Feb 1995 A
5403297 Imran Apr 1995 A
5403326 Harrison et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5413107 Oakley et al. May 1995 A
5421338 Crowley et al. Jun 1995 A
5431649 Mulier et al. Jul 1995 A
5453785 Lenhardt et al. Sep 1995 A
5462521 Brucker et al. Oct 1995 A
5471515 Fossum et al. Nov 1995 A
5487757 Truckai Jan 1996 A
5498230 Adair Mar 1996 A
5505730 Edwards Apr 1996 A
5515853 Smith et al. May 1996 A
5527338 Purdy Jun 1996 A
5549603 Feiring Aug 1996 A
5558619 Kami et al. Sep 1996 A
5571088 Lennox et al. Nov 1996 A
5575756 Karasawa et al. Nov 1996 A
5575810 Swanson et al. Nov 1996 A
5584872 LaFontaine et al. Dec 1996 A
5591119 Adair Jan 1997 A
5593422 Muijs et al. Jan 1997 A
5593424 Northrup, III Jan 1997 A
5611777 Bowden Mar 1997 A
5672153 Lax et al. Sep 1997 A
5676693 LaFontaine Oct 1997 A
5681308 Edwards et al. Oct 1997 A
5695448 Kimura et al. Dec 1997 A
5697281 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5704898 Kokish Jan 1998 A
5709224 Behl et al. Jan 1998 A
5713907 Hogendijk et al. Feb 1998 A
5713946 Ben-Haim Feb 1998 A
5716321 Kerin et al. Feb 1998 A
5722403 McGee et al. Mar 1998 A
5725523 Mueller Mar 1998 A
5746747 McKeating May 1998 A
5749846 Edwards et al. May 1998 A
5749890 Shaknovich May 1998 A
5754313 Pelchy et al. May 1998 A
5766137 Omata Jun 1998 A
5769846 Edwards et al. Jun 1998 A
5792045 Adair Aug 1998 A
5797903 Swanson et al. Aug 1998 A
5823947 Yoon Oct 1998 A
5823955 Kuck Oct 1998 A
5827268 Laufer Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5842973 Bullard Dec 1998 A
5843118 Sepetka et al. Dec 1998 A
5848969 Panescu et al. Dec 1998 A
5860974 Abele Jan 1999 A
5860991 Klein et al. Jan 1999 A
5865791 Whayne et al. Feb 1999 A
5873815 Kerin et al. Feb 1999 A
5879366 Shaw et al. Mar 1999 A
5895417 Pomeranz et al. Apr 1999 A
5897487 Ouchi Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5902328 LaFontaine et al. May 1999 A
5904651 Swanson et al. May 1999 A
5908445 Whayne et al. Jun 1999 A
5925038 Panescu et al. Jul 1999 A
5928250 Koike et al. Jul 1999 A
5929901 Adair et al. Jul 1999 A
5935102 Bowden Aug 1999 A
5938616 Eaton Aug 1999 A
5941845 Tu et al. Aug 1999 A
5944690 Falwell et al. Aug 1999 A
5954654 Eaton Sep 1999 A
5960145 Sanchez Sep 1999 A
5964755 Edwards Oct 1999 A
5968053 Revelas Oct 1999 A
5971983 Lesh Oct 1999 A
5986693 Adair et al. Nov 1999 A
5997571 Farr et al. Dec 1999 A
6004269 Crowley et al. Dec 1999 A
6012457 Lesh Jan 2000 A
6024740 Lesh et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6033378 Lundquist Mar 2000 A
6036685 Mueller Mar 2000 A
6043839 Adair et al. Mar 2000 A
6047218 Whayne et al. Apr 2000 A
6063077 Schaer May 2000 A
6063081 Mulier et al. May 2000 A
6068653 LaFontaine May 2000 A
6071279 Whayne et al. Jun 2000 A
6071302 Sinofsky et al. Jun 2000 A
6081740 Gombrich et al. Jun 2000 A
6086528 Adair Jul 2000 A
6086534 Kesten Jul 2000 A
6099498 Addis Aug 2000 A
6099514 Sharkey et al. Aug 2000 A
6102905 Baxter et al. Aug 2000 A
6112123 Kelleher et al. Aug 2000 A
6115626 Whayne et al. Sep 2000 A
6123699 Webster, Jr. Sep 2000 A
6123703 Tu et al. Sep 2000 A
6123718 Tu et al. Sep 2000 A
6129724 Fleischman et al. Oct 2000 A
6139508 Simpson et al. Oct 2000 A
6142993 Whayne et al. Nov 2000 A
6152144 Lesh et al. Nov 2000 A
6156350 Constantz Dec 2000 A
6159203 Sinofsky Dec 2000 A
6161543 Cox et al. Dec 2000 A
6164283 Lesh Dec 2000 A
6167297 Benaron Dec 2000 A
6168591 Sinofsky Jan 2001 B1
6168594 LaFontaine et al. Jan 2001 B1
6174307 Daniel et al. Jan 2001 B1
6178346 Amundson et al. Jan 2001 B1
6190381 Olsen et al. Feb 2001 B1
6211904 Adair et al. Apr 2001 B1
6224553 Nevo May 2001 B1
6231561 Frazier et al. May 2001 B1
6235044 Root et al. May 2001 B1
6237605 Vaska et al. May 2001 B1
6238393 Mulier et al. May 2001 B1
6240312 Alfano et al. May 2001 B1
6254598 Edwards et al. Jul 2001 B1
6258083 Daniel et al. Jul 2001 B1
6263224 West Jul 2001 B1
6270492 Sinofsky Aug 2001 B1
6275255 Adair et al. Aug 2001 B1
6290689 Delaney et al. Sep 2001 B1
6306081 Ishikawa Oct 2001 B1
6310642 Adair et al. Oct 2001 B1
6311692 Vaska et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6314963 Vaska et al. Nov 2001 B1
6315777 Comben Nov 2001 B1
6315778 Gambale et al. Nov 2001 B1
6322536 Rosengart et al. Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328727 Frazier et al. Dec 2001 B1
6358247 Altman et al. Mar 2002 B1
6358248 Mulier et al. Mar 2002 B1
6375654 McIntyre Apr 2002 B1
6379345 Constantz Apr 2002 B1
6385476 Osadchy et al. May 2002 B1
6387043 Yoon May 2002 B1
6387071 Constantz May 2002 B1
6394096 Constantz May 2002 B1
6396873 Goldstein et al. May 2002 B1
6398780 Farley et al. Jun 2002 B1
6401719 Farley et al. Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
6416511 Lesh et al. Jul 2002 B1
6419669 Frazier et al. Jul 2002 B1
6423051 Kaplan et al. Jul 2002 B1
6423055 Farr et al. Jul 2002 B1
6423058 Edwards et al. Jul 2002 B1
6428536 Panescu et al. Aug 2002 B2
6436118 Kayan Aug 2002 B1
6440061 Wenner et al. Aug 2002 B1
6440119 Nakada et al. Aug 2002 B1
6458076 Pruitt Oct 2002 B1
6458151 Saltiel Oct 2002 B1
6464697 Edwards et al. Oct 2002 B1
6474340 Vaska et al. Nov 2002 B1
6475223 Werp et al. Nov 2002 B1
6478769 Parker Nov 2002 B1
6482162 Moore Nov 2002 B1
6484727 Vaska et al. Nov 2002 B1
6485489 Teirstein et al. Nov 2002 B2
6488671 Constantz et al. Dec 2002 B1
6494902 Hoey et al. Dec 2002 B2
6497705 Comben Dec 2002 B2
6500174 Maguire et al. Dec 2002 B1
6502576 Lesh Jan 2003 B1
6514249 Maguire et al. Feb 2003 B1
6517533 Swaminathan Feb 2003 B1
6527979 Constantz et al. Mar 2003 B2
6532380 Close et al. Mar 2003 B1
6533767 Johansson et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6540733 Constantz et al. Apr 2003 B2
6540744 Hassett et al. Apr 2003 B2
6544195 Wilson et al. Apr 2003 B2
6547780 Sinofsky Apr 2003 B1
6558375 Sinofsky et al. May 2003 B1
6558382 Jahns et al. May 2003 B2
6562020 Constantz et al. May 2003 B1
6572609 Farr et al. Jun 2003 B1
6579285 Sinofsky Jun 2003 B2
6585732 Mulier et al. Jul 2003 B2
6587709 Solf et al. Jul 2003 B2
6593884 Gilboa et al. Jul 2003 B1
6605055 Sinofsky et al. Aug 2003 B1
6613062 Leckrone et al. Sep 2003 B1
6622732 Constantz Sep 2003 B2
6626855 Weng et al. Sep 2003 B1
6626900 Sinofsky et al. Sep 2003 B1
6635070 Leeflang et al. Oct 2003 B2
6645202 Pless et al. Nov 2003 B1
6650923 Lesh et al. Nov 2003 B1
6658279 Swanson et al. Dec 2003 B2
6659940 Adler Dec 2003 B2
6673090 Root et al. Jan 2004 B2
6676656 Sinofsky Jan 2004 B2
6679836 Couvillon, Jr. et al. Jan 2004 B2
6682526 Jones et al. Jan 2004 B1
6689128 Sliwa et al. Feb 2004 B2
6692430 Adler Feb 2004 B2
6701581 Senovich et al. Mar 2004 B2
6701931 Sliwa et al. Mar 2004 B2
6702780 Gilboa et al. Mar 2004 B1
6704043 Goldstein et al. Mar 2004 B2
6706039 Mulier et al. Mar 2004 B2
6712798 Constantz Mar 2004 B2
6719747 Constantz et al. Apr 2004 B2
6719755 Sliwa et al. Apr 2004 B2
6730063 Delaney et al. May 2004 B2
6736810 Hoey et al. May 2004 B2
6755811 Constantz May 2004 B1
6751492 Ben-Haim Jun 2004 B2
6755790 Stewart et al. Jun 2004 B2
6764487 Mulier et al. Jul 2004 B2
6771996 Bowe et al. Aug 2004 B2
6773402 Govari et al. Aug 2004 B2
6780151 Grabover Aug 2004 B2
6805128 Pless et al. Oct 2004 B1
6805129 Pless et al. Oct 2004 B1
6811532 Ogura Nov 2004 B2
6811562 Pless Nov 2004 B1
6833814 Gilboa et al. Dec 2004 B2
6840923 Lapcevic Jan 2005 B1
6840936 Sliwa et al. Jan 2005 B2
6849073 Hoey et al. Feb 2005 B2
6858005 Ohline Feb 2005 B2
6858026 Sliwa et al. Feb 2005 B2
6863668 Gillespie et al. Mar 2005 B2
6866651 Constantz Mar 2005 B2
6887237 McGaffigan May 2005 B2
6892091 Ben-Haim Shlomo et al. May 2005 B1
6896690 Lambrecht et al. May 2005 B1
6899672 Chin et al. May 2005 B2
6915154 Docherty et al. Jul 2005 B1
6916284 Moriyama Jul 2005 B2
6923805 LaFontaine et al. Aug 2005 B1
6926669 Stewart Aug 2005 B1
6929010 Vaska et al. Aug 2005 B2
6932809 Sinofsky Aug 2005 B2
6939348 Malecki et al. Sep 2005 B2
6942657 Sinofsky et al. Sep 2005 B2
6949095 Vaska et al. Sep 2005 B2
6953457 Farr et al. Oct 2005 B2
6955173 Lesh Oct 2005 B2
6962589 Mulier et al. Nov 2005 B2
6971394 Sliwa et al. Dec 2005 B2
6974464 Quijano et al. Dec 2005 B2
6979290 Mourlas et al. Dec 2005 B2
6982740 Adair et al. Jan 2006 B2
6984232 Vanney et al. Jan 2006 B2
6994094 Schwartz Feb 2006 B2
7019610 Creighton et al. Mar 2006 B2
7025746 Tal Apr 2006 B2
7030904 Adair et al. Apr 2006 B2
7041098 Farley et al. May 2006 B2
7042487 Nakashima May 2006 B2
7044135 Lesh May 2006 B2
7052493 Vaska et al. May 2006 B2
7090683 Brock et al. Aug 2006 B2
7112195 Boll Sep 2006 B2
7118566 Jahns Oct 2006 B2
7156845 Mulier et al. Jan 2007 B2
7163534 Brucker et al. Jan 2007 B2
7166537 Jacobsen et al. Jan 2007 B2
7169144 Hoey et al. Jan 2007 B2
7186214 Ness Mar 2007 B2
7207984 Farr et al. Apr 2007 B2
7217268 Eggers et al. May 2007 B2
7242832 Carlin et al. Jul 2007 B2
7247155 Hoey et al. Jul 2007 B2
7261711 Mulier et al. Aug 2007 B2
7263397 Hauck et al. Aug 2007 B2
7276061 Schaer Oct 2007 B2
7309328 Kaplan et al. Dec 2007 B2
7416552 Paul et al. Aug 2008 B2
7435248 Taimisto et al. Oct 2008 B2
7527625 Knight et al. May 2009 B2
7534204 Starksen et al. May 2009 B2
7569052 Phan Aug 2009 B2
7682319 Martin Mar 2010 B2
7736347 Kaplan et al. Jun 2010 B2
7758499 Adler Jul 2010 B2
7803168 Gifford Sep 2010 B2
7815564 Geitz Oct 2010 B2
7815566 Stefanchik Oct 2010 B2
7860555 Saadat Dec 2010 B2
7860556 Saadat Dec 2010 B2
7988619 Longo Aug 2011 B2
8052607 Byrd Nov 2011 B2
8131350 Saadat et al. Mar 2012 B2
8137333 Saadat et al. Mar 2012 B2
8235985 Saadat et al. Aug 2012 B2
8303487 Ueno Nov 2012 B2
8465420 Ostrovsky Jun 2013 B2
8657805 Peh Feb 2014 B2
9101735 Rothe et al. Aug 2015 B2
9144369 Ostrovsky Sep 2015 B2
9668641 Ostrovsky Jun 2017 B2
10123682 Ostrovsky Nov 2018 B2
20010020126 Swanson et al. Sep 2001 A1
20010039416 Moorman et al. Nov 2001 A1
20010047136 Domanik et al. Nov 2001 A1
20010047184 Connors Nov 2001 A1
20020004644 Koblish Jan 2002 A1
20020026145 Bagaoisan et al. Feb 2002 A1
20020054852 Cate May 2002 A1
20020065455 Ben-Haim et al. May 2002 A1
20020087169 Brock et al. Jul 2002 A1
20020091304 Ogura Jul 2002 A1
20020138088 Nash et al. Sep 2002 A1
20020165598 Wahr et al. Nov 2002 A1
20020169377 Khairkhahan et al. Nov 2002 A1
20030009085 Arai et al. Jan 2003 A1
20030035156 Cooper Feb 2003 A1
20030036698 Kohler et al. Feb 2003 A1
20030069593 Tremulis et al. Apr 2003 A1
20030120142 Dubuc et al. Jun 2003 A1
20030130572 Phan et al. Jul 2003 A1
20030144657 Bowe et al. Jul 2003 A1
20030171741 Ziebol et al. Sep 2003 A1
20030181939 Bonutti Sep 2003 A1
20030208222 Zadno-Azizi Nov 2003 A1
20030212394 Pearson et al. Nov 2003 A1
20030220574 Markus et al. Nov 2003 A1
20030222325 Jacobsen et al. Dec 2003 A1
20040049211 Tremulis et al. Mar 2004 A1
20040054335 Lesh et al. Mar 2004 A1
20040054389 Osypka Mar 2004 A1
20040082833 Adler et al. Apr 2004 A1
20040097788 Mourlas May 2004 A1
20040117032 Roth May 2004 A1
20040106850 Yamaya Jun 2004 A1
20040133113 Krishnan Jul 2004 A1
20040138707 Greenhalgh Jul 2004 A1
20040147806 Adler Jul 2004 A1
20040147911 Sinofsky Jul 2004 A1
20040147912 Sinofsky Jul 2004 A1
20040147913 Sinofsky Jul 2004 A1
20040158124 Okada Aug 2004 A1
20040158143 Flaherty et al. Aug 2004 A1
20040158289 Girouard et al. Aug 2004 A1
20040167503 Sinofsky Aug 2004 A1
20040181237 Forde et al. Sep 2004 A1
20040199052 Banik et al. Oct 2004 A1
20040210239 Nash et al. Oct 2004 A1
20040215180 Starkebaum et al. Oct 2004 A1
20040220471 Schwartz Nov 2004 A1
20040230131 Kassab et al. Nov 2004 A1
20040236316 Danitz Nov 2004 A1
20040242960 Orban, III Dec 2004 A1
20040248837 Raz et al. Dec 2004 A1
20040249367 Saadat Dec 2004 A1
20040254523 Fitzgerald et al. Dec 2004 A1
20040260182 Zuluaga et al. Dec 2004 A1
20050014995 Amundson et al. Jan 2005 A1
20050015048 Chiu et al. Jan 2005 A1
20050020914 Amundson et al. Jan 2005 A1
20050027163 Chin et al. Feb 2005 A1
20050038317 Ratnakar Feb 2005 A1
20050038419 Arnold et al. Feb 2005 A9
20050059862 Phan Mar 2005 A1
20050059954 Constantz Mar 2005 A1
20050059962 Phan Mar 2005 A1
20050059965 Eberl et al. Mar 2005 A1
20050065504 Melsky et al. Mar 2005 A1
20050090818 Pike et al. Apr 2005 A1
20050096643 Brucker et al. May 2005 A1
20050101984 Chanduszko et al. May 2005 A1
20050107667 Danitz May 2005 A1
20050107736 Landman et al. May 2005 A1
20050119523 Starksen Jun 2005 A1
20050124969 Fitzgerald Jun 2005 A1
20050131401 Malecki Jun 2005 A1
20050154252 Sharkey et al. Jul 2005 A1
20050159702 Sekiguchi et al. Jul 2005 A1
20050165279 Adler et al. Jul 2005 A1
20050165391 Maguire et al. Jul 2005 A1
20050165466 Morris Jul 2005 A1
20050182465 Ness Aug 2005 A1
20050197530 Wallace et al. Sep 2005 A1
20050197623 Leeflang et al. Sep 2005 A1
20050215895 Popp et al. Sep 2005 A1
20050222557 Baxter et al. Oct 2005 A1
20050222558 Baxter et al. Oct 2005 A1
20050228452 Mourlas et al. Oct 2005 A1
20050234436 Baxter et al. Oct 2005 A1
20050234437 Baxter et al. Oct 2005 A1
20050267328 Blumzvig et al. Dec 2005 A1
20050272975 McWeeney Dec 2005 A1
20050273085 Hinman Dec 2005 A1
20060009715 Khairkhahan et al. Jan 2006 A1
20060009737 Whiting et al. Jan 2006 A1
20060015096 Hauck et al. Jan 2006 A1
20060022234 Adair et al. Feb 2006 A1
20060025651 Adler et al. Feb 2006 A1
20060025787 Morales et al. Feb 2006 A1
20060041188 Dirusso Feb 2006 A1
20060069303 Couvillon, Jr. Mar 2006 A1
20060074398 Whiting et al. Apr 2006 A1
20060084839 Mourlas Apr 2006 A1
20060084945 Moll Apr 2006 A1
20060089637 Werneth et al. Apr 2006 A1
20060094931 Danitz May 2006 A1
20060111614 Saadat et al. May 2006 A1
20060111615 Danitz May 2006 A1
20060122587 Sharareh Jun 2006 A1
20060142694 Bednarek Jun 2006 A1
20060146172 Jacobsen et al. Jul 2006 A1
20060149331 Mann et al. Jul 2006 A1
20060155242 Constantz Jul 2006 A1
20060161133 Laird et al. Jul 2006 A1
20060167439 Kalser et al. Jul 2006 A1
20060178560 Saadat Aug 2006 A1
20060183992 Kawashima Aug 2006 A1
20060200000 Sato Sep 2006 A1
20060217755 Eversull et al. Sep 2006 A1
20060224167 Weisenburgh et al. Oct 2006 A1
20060252993 Freed Nov 2006 A1
20060253113 Arnold et al. Nov 2006 A1
20060258909 Saadat et al. Nov 2006 A1
20060271032 Chin Nov 2006 A1
20070005019 Okishige Jan 2007 A1
20070010708 Ness Jan 2007 A1
20070015964 Eversull et al. Jan 2007 A1
20070016130 Leeflang et al. Jan 2007 A1
20070043338 Moll et al. Feb 2007 A1
20070043413 Eversull et al. Feb 2007 A1
20070049923 Jahns Mar 2007 A1
20070055142 Webler Mar 2007 A1
20070078451 Arnold et al. Apr 2007 A1
20070083187 Eversull et al. Apr 2007 A1
20070083217 Eversull et al. Apr 2007 A1
20070093808 Mulier et al. Apr 2007 A1
20070100324 Tempel et al. May 2007 A1
20070106146 Altmann et al. May 2007 A1
20070106214 Gray et al. May 2007 A1
20070106287 O'Sullivan May 2007 A1
20070135826 Zaver et al. Jun 2007 A1
20070167801 Webler et al. Jul 2007 A1
20070260223 Scheibe Nov 2007 A1
20070265609 Thapliyal et al. Nov 2007 A1
20070265610 Thapliyal et al. Nov 2007 A1
20070270686 Ritter et al. Nov 2007 A1
20070282371 Lee et al. Dec 2007 A1
20070287886 Saadat Dec 2007 A1
20070293724 Saadat et al. Dec 2007 A1
20080009747 Saadat et al. Jan 2008 A1
20080009859 Auth et al. Jan 2008 A1
20080015563 Hoey et al. Jan 2008 A1
20080015569 Saadat et al. Jan 2008 A1
20080021277 Stefanchik Jan 2008 A1
20080027464 Moll Jan 2008 A1
20080033241 Peh et al. Feb 2008 A1
20080035701 Racenet et al. Feb 2008 A1
20080039690 Zubiate Feb 2008 A1
20080051631 Dejima Feb 2008 A1
20080057106 Erickson et al. Mar 2008 A1
20080058590 Saadat et al. Mar 2008 A1
20080058650 Saadat et al. Mar 2008 A1
20080058836 Moll Mar 2008 A1
20080097476 Peh et al. Apr 2008 A1
20080183081 Lys et al. Jul 2008 A1
20080188759 Saadat et al. Aug 2008 A1
20080214889 Saadat et al. Sep 2008 A1
20080214890 Motai Sep 2008 A1
20080228032 Starksen et al. Sep 2008 A1
20080249356 Motai Oct 2008 A1
20080275300 Rothe et al. Nov 2008 A1
20080281293 Peh et al. Nov 2008 A1
20080287741 Ostrovsky Nov 2008 A1
20080287790 Li Nov 2008 A1
20080287805 Li Nov 2008 A1
20080287961 Miyamoto Nov 2008 A1
20080300462 Intoccia Dec 2008 A1
20090030276 Saadat et al. Jan 2009 A1
20090030412 Willis et al. Jan 2009 A1
20090054803 Saadat et al. Feb 2009 A1
20090062790 Malchano et al. Mar 2009 A1
20090069694 Amundson Mar 2009 A1
20090076489 Welches et al. Mar 2009 A1
20090082623 Rothe et al. Mar 2009 A1
20090125022 Saadat et al. May 2009 A1
20090137875 Kitagawa May 2009 A1
20090143640 Saadat et al. Jun 2009 A1
20090187074 Saadat et al. Jul 2009 A1
20090203962 Miller et al. Aug 2009 A1
20090221871 Peh et al. Sep 2009 A1
20090227999 Willis et al. Sep 2009 A1
20090264727 Markowitz et al. Oct 2009 A1
20090264759 Byrd Oct 2009 A1
20090267773 Markowitz et al. Oct 2009 A1
20090275799 Saadat et al. Nov 2009 A1
20090281524 Scheibe Nov 2009 A1
20090299363 Saadat et al. Dec 2009 A1
20090326572 Peh et al. Dec 2009 A1
20100004506 Saadat Jan 2010 A1
20100004661 Verin et al. Jan 2010 A1
20100010311 Miller et al. Jan 2010 A1
20100094081 Rothe et al. Apr 2010 A1
20100130836 Malchano et al. May 2010 A1
20110060227 Saadat Mar 2011 A1
20110060298 Saadat Mar 2011 A1
20110144576 Rothe et al. Jun 2011 A1
20120016221 Saadat et al. Jan 2012 A1
20120059366 Drews et al. Mar 2012 A1
20120150046 Watson et al. Jun 2012 A1
20130060239 Hinman Mar 2013 A1
20130261397 Ostrovsky Oct 2013 A1
20140358088 Miyamoto Dec 2014 A1
20150359417 Ostrovsky Dec 2015 A1
20170231475 McWeeney Aug 2017 A1
Foreign Referenced Citations (39)
Number Date Country
10028155 Dec 2000 DE
0283661 Sep 1988 EP
0301288 Feb 1989 EP
S5993413 May 1984 JP
S59181315 Oct 1984 JP
H01221133 Sep 1989 JP
H03284265 Dec 1991 JP
H05103746 Apr 1993 JP
H0951897 Feb 1997 JP
H11299725 Nov 1999 JP
2001258822 Sep 2001 JP
WO-9221292 Dec 1992 WO
WO-9407413 Apr 1994 WO
WO-9503843 Feb 1995 WO
WO-9818388 May 1998 WO
WO-03039350 May 2003 WO
WO-03053491 Jul 2003 WO
WO-03101287 Dec 2003 WO
WO-2004043272 May 2004 WO
WO-2004080508 Sep 2004 WO
WO-2005070330 Aug 2005 WO
WO-2005077435 Aug 2005 WO
WO-2005081202 Sep 2005 WO
WO-2006017517 Feb 2006 WO
WO-2006024015 Mar 2006 WO
WO-2006083794 Aug 2006 WO
WO-2006091597 Aug 2006 WO
WO-2006126979 Nov 2006 WO
WO-2007067323 Jun 2007 WO
WO-2007079268 Jul 2007 WO
WO-2007133845 Nov 2007 WO
WO-2007134258 Nov 2007 WO
WO2008015625 Feb 2008 WO
WO2008021994 Feb 2008 WO
WO-2008021997 Feb 2008 WO
WO-2008021998 Feb 2008 WO
WO-2008024261 Feb 2008 WO
WO-2008079828 Jul 2008 WO
WO-2009112262 Sep 2009 WO
Non-Patent Literature Citations (76)
Entry
Avitall B., et al., “Right-Sided Driven Atrial Fibrillation in a Sterile Pericarditis Dog Model,” Pacing and Clinical Electrophysiology, 1994, vol. 17, pp. 774.
Avitall, et al., “A Catheter System to Ablate Atrial Fibrillation in a Sterile Pericarditis Dog Model,” Pacing arid Clinical Electrophysiology, 1994, vol. 17, pp. 774.
Avitall, “Vagally Mediated Atrial Fibrillation in a Dog Model can be Ablated by Placing Linear Radiofrequency Lesions at the Junction of the Right Atrial Appendage and the Superior Vena Cava,” Pacing and Clinical Electrophysiology 1995, vol. 18, pp. 857.
Baker B.M., et al., “Nonpharmacologic Approaches to the Treatment of Atrial Fibrillation and Atrial Flutter,” Journal of Cardiovascular Electrophysiology, 1995 vol. 6 (10 Pt 2), pp. 972-978.
Bhakta D., et al., “Principles of Electroanatomic Mapping,” Indian Pacing and Electrophysiology Journal, 2008, vol. 8 (1), pp. 32-50.
Bidoggia H., et al., “Transseptal Left Heart Catheterization Usefulness of the intracavitary Electrocardiogram in the Localization of the Fossa Ovalis,” Cathet Cardiovasc Diagn, 1991, vol. 24(3), pp. 221-225, PMID: 1764747 [online], [retrieved Feb. 15, 2010]. Retrieved from the Internet: &It;URL: http://www.ncbi.nim.nih.gov/sites/entrez&gt.
Bredikis J.J., etal., “Surgery of Tachyarrhythmia: intracardiac Closed Heart Cryoablation,” Pacing and Clinical Electrophysiology, 1990. vol. 13 (Part 2), pp. 1980-1984.
Communication from the Examining Division for Application No. EP06734083.6 dated Nov. 12, 2010, 3 pages.
Communication from the Examining Division for Application No. EP06734083.6 dated Oct. 23, 2009, 1 page.
Communicaton from the Examining Division for Application No. EP08746822.9 dated Jul. 13, 2010, 1 page.
U.S. Appl. No. 61/286,283, filed Dec. 14, 2009.
U.S. Appl. No. 61/297,462, filed Jan. 22, 2010.
Cox J.L., “Cardiac Surgery for Arrhythmias,” Journal of Cardiovascular Electrophysiology, 2004, vol. 15, pp. 250-262.
Cox J.L., el al., “Five-Year Experience With the Maze Procedure for Atrial Fibrillation,” The Annals of Thoracic Surgery, 1993, vol. 56, pp. 814-824.
Cox J.L., el al., “Modification of the Maze Procedure for Atrial Flutter and Atrial Fibrillation,” The Journal of Thoracic and Cardiovascular Surgery, 1995, vol. 110, pp. 473-484.
Cox J.L., “The Status of Surgery for Cardiac Arhythmas,” Circulation, 1985. Vol. 71, pp. 413-417.
Cox J.L., “The Surgical Treatment of Atrial Fibrillation,” The Journal of Thoracic and Cardiovascular Surgery, 1991, vol. 101, pp. 584-592.
Elvan A., et al., “Radiofrequency Catheter Ablation of the Atria Reduces inducibility and Duration of Atrial Fibrillation in Dogs,” Circulation, vol. 91, 1995, pp. 2235-2244 [online], [retrieved Feb. 4, 2013]. Retrieved from the Internet: <URL: http://circ.ahajournais.org/cgi/content/full/91/8/2235&gt.
Elvan A., et al., “Radiofrequency Catheter Ablation (RFCA) of the Atria Effectively Abolishes Pacing Induced Chronic Atrial Fibrillation,” Pacing and Clinical Electrophysiology, 1995, vol. 18, pp. 856.
Elvan, et al., “Replication of the ‘Maze’ Procedure by Radiofrequency Catheter Ablation Reduces the Ability to Induce Atrial Fibrillation,” Pacing and Clinical Electrophysiology, 1994, vol. 17 , pp. 774.
European Search Report for Application No. EP07799466.3 dated Nov. 18, 2010, 9 pages.
European Search Report for Application No. EP08746822.9 dated Mar. 29, 2010, 7 Pages.
Examination Communication for Application No. EP06734083.6 dated May 18, 2010, 3 Pages.
Extended European Search Report for Application No. EP06734083.6 dated Jul. 1, 2009, 6 pages.
Fieguth H.G., et al., “Inhibition of Atrial Fibrillation by Pulmonary Vein Isolation and Auricular Resection—Experimental Study in a Sheep Model,” The European Journal of Cardio-Thoracic Surgery, 1997, vol. 11, pp. 714-721.
Final Office Action dated Mar. 1, 2010 for U.S. Appl. No. 12/117,655 filed May 8, 2008.
Final Office Action dated Jun. 2, 2011 for U.S. Appl. No. 12/117,655, filed May 8, 2008.
Final Office Action dated May 12, 2011 for U.S. Appl. No. 11/775,771, filed Jul. 10, 2007.
Final Office Action dated Sep. 16, 2010 for U.S. Appl. No. 11/828,267, filed Jul. 25, 2007.
Hoey M.F., et al., “Intramural Ablation Using Radiofrequency Energy Via Screw-Tip Catheter and Saline Electrode,” Pacing and Clinical Electrophysiology, 1995, vol. 18. Part II, 487.
Huang, “Increase in the Lesion Size and Decrease in the Impedance Rise with a Saline Infusion Electrode Catheter for Radiofrequency,” Circulation, 1989, vol. 80 (4), II-324.
Moser K.M ., et al., “Angioscopic Visualization of Pulmonary Emboli,” Chest, 1980, vol. 77 (2), pp. 198-201.
Nakamura F., et al., “Percutaneous Intracardiac Surgery With Cardioscopic Guidance,” SPIE, 1992, vol. 1642, pp. 214-216.
Non-Final Office Action dated Jun. 7, 2011 for U.S. Appl. No. 12/323,281, filed Nov. 25, 2008.
Non-Final Office Action dated Jun. 8, 2009 for U.S. Appl. No. 12/117,655, filed May 8, 2008.
Non-Final Office Action dated May 9, 2011 for U.S. Appl. No. 11/961,950 filed Dec. 28, 2007.
Non-Final Office Action dated May 9, 2011 for U.S. Appl. No. 11/961,995, filed Dec. 20, 2007.
Non-Final Office Action dated May 9, 2011 for U.S. Appl. No. 11/962,029, filed Dec. 20, 2007.
Non-Final Office Action dated Jun. 10, 2010 for U.S. Appl. No. 11/560,742, filed Nov. 16, 2006.
Non-Final Office Action dated Apr. 11, 2011 for U.S. Appl. No. 11/763,399, filed Jun. 14, 2007.
Non-Final Office Action dated Mar. 11, 2011 for U.S. Appl. No. 11/848,202, filed Aug. 30, 2007.
Non-Final Office Action dated May 11, 2011 for U.S. Appl. No. 11/828,267, filed Jul. 25, 2007.
Non-Final Office Action dated Jan. 14, 2010 for U.S. Appl. No. 11/828,267 filed Jun. 25, 2007.
Non-Final Office Action dated Dec. 16, 2010 for U.S. Appl. No. 12/117,655, fied May 8, 2008.
Non-Final Office Action dated Feb. 18, 2011 for U.S. Appl. No. 12/947,198, filed Nov. 16, 2010.
Non-Final Office Action dated Feb. 18, 2011 for U.S. Appl. No. 12/947,246, filed Nov. 16, 2006.
Non-Final Office Action dated May 20, 2011 for U.S. Appl. No. 11/775,819, filed Jul. 10, 2007.
Non-Final Office Action dated May 20, 2011 for U.S. Appl. No. 11/877,386, filed Oct. 23, 2007.
Non-Final Office Action dated Jul. 21, 2010 for U.S. Appl. No. 11/687,597, filed Mar. 16, 2007.
Non-Final Office Action dated Apr. 22, 2011 for U.S. Appl. No. 12/367,019, filed Feb. 6, 2009.
Non-Final Office Action dated May 23, 2011 for U.S. Appl. No. 11/775,837, filed Jul. 10, 2007.
Non-Final Office Action dated Nov. 24, 2010 for U.S. Appl. No. 11/848,429, filed Aug. 31, 2007.
Non-Final Office Action dated Nov. 24, 2010 for U.S. Appl. No. 12/464,800, filed May 12, 2009.
Non-Final Office Action dated Apr. 25, 2011 for U.S. Appl. No. 11/959,158, filed Dec. 18, 2007.
Non-Final Office Action dated Feb. 25, 2010 for U.S. Appl. No. 11/259,498, filed Oct. 25, 2005.
Non-Final Office Action dated Feb. 25, 2011 for U.S. Appl. No. 11/848,207, filed Aug. 30, 2007.
Non-Final Office Action dated Apr. 26, 2011 for U.S. Appl. No. 11/848,532, filed Aug. 31, 2007.
Non-Final Office Action dated Apr. 27, 2011 for U.S. Appl. No. 11/828,281, filed Jul. 25, 2007.
Non-Final Office Action dated Aug. 27, 2010 for U.S. Appl. No. 11/775,771, filed Jul. 10, 2007.
Non-Final Office Action dated Dec. 27, 2010 for U.S. Appl. No. 12/026,456, filed Feb. 5, 2008.
Notice of Allowance dated Feb. 3, 2011 for U.S. Appl. No. 11/560,732, filed Nov. 16, 2006.
Notice of Allowance dated Jun. 13, 2011 for Japanese Application No. 2007-554156 filed Jan. 30, 2006.
Notice of Allowance dated Nov. 15, 2010 for U.S. Appl. No. 11/258,498, filed Oct. 25, 2005.
Notice of Allowance dated Nov. 15, 2010 for U.S. Appl. No. 11/560,742, filed Nov. 16, 2006.
Notice of Allowance dated Feb. 24, 2011 for U.S. Appl. No. 11/580,732, filed May 16, 2007.
Notice of Allowance dated Feb. 24, 2011 for U.S. Appl. No. 11/687,597, filed Mar. 16, 2007.
Office Action dated Feb. 15, 2011 for Japanese Application No. 2007-554156 filed Jan. 30, 2006.
Office Action dated Apr. 27, 2011 for Japanese Application No. 2009-500630 filed Mar. 16, 2007.
Pappone C., et al., “Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia,” Circulation, 2000, vol. 102 pp. 2619-2628.
Sethi K.K., et al., “Transseptal catheterization for the electrophysiologist modification with a ‘view’,” Joumas of Interventional Cardiac Electrophysiology, 2001, vol. 5 (1), pp. 97-99.
Supplemental European Search Report for Application No. EP07756716 dated Feb. 28, 2011, 8 Pages.
Supplementary European search report for Application No. EP07812146.4 dated Nov. 18, 2010, 8 Pages.
Supplementary European Search Report for Application No. EP07841754, dated Jun. 30, 2010, 6 pages.
Thiagalingam A., et al., “Cooled Needle Catheter Ablation Creates Deeper and Wider Lesions than irrigated Tip Catheter Ablation,” Journal of Cardiovascular Electrophysiology, 2005, vol. 16 (5), pp. 1-8.
Uchiday., “Developmental History of Cardioscopes” in: Coronary Angioscopy, Chapter 19, Future Publishing Company, Inc., 2001, pp. 187-197.
Willkampf F.H., et al., Radiofrequency Ablation with a Cooled Porous Electrode Catheter, JACC, Abstract, 1988, vol. 11 (2), pp. 17A.
Related Publications (1)
Number Date Country
20150314107 A1 Nov 2015 US
Provisional Applications (1)
Number Date Country
61078746 Jul 2008 US
Continuations (1)
Number Date Country
Parent 12499011 Jul 2009 US
Child 14795325 US